Stem cell therapy for autoimmune disease: overview of concepts from the Snowbird 2002 tolerance and tissue regeneration meeting.
Hematopoietic stem cell transplantation as a treatment for autoimmune disease began in 1996 and has subsequently spread worldwide. In Europe phase III trials have opened, while in America phase III trials are being designed and funded by the National Institutes of Health. On 6 June 2002, clinicians and scientists from around the world met at Snowbird, Utah to discuss the results and future directions of stem cell therapy for autoimmune diseases. What follows are general concepts from chairpersons of this meeting.
Burt
R K
RK
Northwestern University Medical Center, 320 East Superior, Searle, Room 3-489 Chicago, IL 60611, USA. rburt@nwu.edu
Arnold
R
R
Emmons
R
R
Oyama
Y
Y
Marmont
A
A
D001327:Autoimmune Diseases / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D012038:Regeneration; D019172:Transplantation Conditioning / Q000379:methods